Laurel Wealth Advisors (California)’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Laurel Wealth Advisors (California)'s MDT Position: Q4 2022 in Review
Laurel Wealth Advisors (California) increased its Medtronic (MDT) stake by 23% in Q4 2022, buying an estimated $401K and bringing the position to 26,215 shares worth $2.04M. The position accounts for 0.2% of the portfolio, ranked #117.
Laurel Wealth Advisors (California) first reported a position in MDT in Q4 2017 and has held it in 19 quarters since. 1,962 funds tracked by Wall St. Rank hold MDT as of Q4 2022.
- Laurel Wealth Advisors (California) held 26,215 shares of Medtronic worth $2.04M as of Q4 2022.
- Laurel Wealth Advisors (California) bought 4,953 Medtronic shares in Q4 2022, an estimated $401K.
- Medtronic made up 0.2% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #117 holding.
- Laurel Wealth Advisors (California) first reported a position in Medtronic in Q4 2017 and has held it in 19 quarters since.
- 1,962 funds tracked by Wall St. Rank held Medtronic as of Q4 2022.
Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.